Media Inquiries
- 615-322-6397 Email
Latest Stories
- Team from Vanderbilt’s LIVE Initiative advances to finals of NSF challenge to improve K-12 learning outcomes
- Vanderbilt highlights smart mobility research, innovative solutions at Nashville expo
- Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
